FRANKLIN RESOURCES INC - TURKCELL ILETISIM HIZMETLERI ownership

TURKCELL ILETISIM HIZMETLERI's ticker is TKC and the CUSIP is 900111204. A total of 92 filers reported holding TURKCELL ILETISIM HIZMETLERI in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
FRANKLIN RESOURCES INC ownership history of TURKCELL ILETISIM HIZMETLERI
ValueSharesWeighting
Q3 2017$147,000
-99.9%
16,661
-99.9%
0.00%
-100.0%
Q2 2017$122,960,000
-25.8%
14,995,089
-25.1%
0.06%
-27.4%
Q1 2017$165,760,000
-3.6%
20,019,313
-19.7%
0.08%
-5.6%
Q4 2016$171,929,000
-23.9%
24,917,384
-11.1%
0.09%
-24.6%
Q3 2016$225,894,000
-13.6%
28,026,572
-2.0%
0.12%
-16.3%
Q2 2016$261,562,000
-13.4%
28,585,867
-0.5%
0.14%
-11.9%
Q1 2016$301,872,000
+23.2%
28,722,328
-0.5%
0.16%
+29.0%
Q4 2015$245,009,000
-6.7%
28,858,657
-4.6%
0.12%
-4.6%
Q3 2015$262,680,000
-23.4%
30,262,754
+1.4%
0.13%
-16.7%
Q2 2015$343,069,000
-11.7%
29,858,006
+0.1%
0.16%
-11.4%
Q1 2015$388,623,000
-15.7%
29,825,217
-2.2%
0.18%
-15.8%
Q4 2014$461,182,000
+15.2%
30,501,379
+0.1%
0.21%
+14.2%
Q3 2014$400,505,000
-15.5%
30,479,829
+0.4%
0.18%
-12.4%
Q2 2014$473,731,000
+15.5%
30,367,377
+1.9%
0.21%
+7.7%
Q1 2014$410,269,000
+52.2%
29,794,411
+47.6%
0.19%
+47.0%
Q4 2013$269,502,000
-8.5%
20,187,407
+1.1%
0.13%
-15.9%
Q3 2013$294,544,000
-0.0%
19,969,001
-2.6%
0.16%
-6.5%
Q2 2013$294,666,00020,505,6060.17%
Other shareholders
TURKCELL ILETISIM HIZMETLERI shareholders Q4 2016
NameSharesValueWeighting ↓
Arlington Capital Management, Inc. 319,608$1,511,7461.58%
Discerene Group LP 643,069$3,041,7160.37%
O'SHAUGHNESSY ASSET MANAGEMENT, LLC 1,753,820$8,295,5690.12%
RITHOLTZ WEALTH MANAGEMENT 433,626$2,051,0520.09%
First Trust Direct Indexing L.P. 137,366$649,7410.07%
Warren Street Wealth Advisors, LLC 16,220$76,7210.05%
Claret Asset Management Corp 47,350$2240.04%
West Family Investments, Inc. 19,647$92,9300.03%
Colonial River Wealth Management, LLC 10,065$47,6070.03%
QUADRANT CAPITAL GROUP LLC 62,228$294,3390.03%
View complete list of TURKCELL ILETISIM HIZMETLERI shareholders